in this issue
Markets :: Fine Chemicals/Biotech :: Seeds and traits
Bayer and Evogene Sign Deal to Improve Wheat
4:03 AM MST | December 13, 2010 | Alex Scott
Bayer CropScience and Evogene (Rehovot, Israel), an agchems firm, have signed a five-year agreement to collaborate on the development of novel species of wheat using both advanced breeding and genetic modification techniques. The focus of the R&D will be on optimizing wheat’s yield, drought tolerance and requirements for fertilizer use, as well as the enhancement of other traits, Bayer says. Bayer will pay Evogene approximately $20 million in upfront fees and annual research payments over the term of the agreement. Evogene also will receive...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee